We are live on ! Find out more
EIGR

Eiger BioPharmaceuticals, Inc.
EIGR

Delisted

EIGR was delisted on the 10th of April, 2024.

Back to rankings

34 hedge funds and large institutions have $73.1M invested in Eiger BioPharmaceuticals, Inc. in 2014 Q1 according to their latest regulatory filings, with 34 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
34
Holders Change
+34
Holders Change %
–
% of All Funds
0.98%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
34
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
PAI
Palo Alto Investors
California
+$15.7M
2
MAM
MPM Asset Management
Massachusetts
+$11.2M
3
TCM
Tekla Capital Management
Massachusetts
+$10.2M
4
JP Morgan Chase
JP Morgan Chase
New York
+$5.49M
5
PHS
PFM Health Sciences
California
+$4.05M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
PAI
1
Palo Alto Investors
California
$17.8M +$15.7M +3,314 New
MAM
2
MPM Asset Management
Massachusetts
$12.7M +$11.2M +2,371 New
TCM
3
Tekla Capital Management
Massachusetts
$9.83M +$10.2M +2,157 New
JP Morgan Chase
4
JP Morgan Chase
New York
$6.23M +$5.49M +1,162 New
PHS
5
PFM Health Sciences
California
$4.59M +$4.05M +856 New
VAM
6
Visium Asset Management
New York
$4.38M +$3.86M +816 New
FCM
7
Farallon Capital Management
California
$3.24M +$2.85M +604 New
California Public Employees Retirement System
8
California Public Employees Retirement System
California
$3.15M +$3.15M +667 New
BFA
9
BlackRock Fund Advisors
California
$2.06M +$1.82M +385 New
HighTower Advisors
10
HighTower Advisors
Illinois
$1.59M +$1.4M +296 New
Vanguard Group
11
Vanguard Group
Pennsylvania
$1.2M +$1.06M +224 New
BIT
12
BlackRock Institutional Trust
California
$1.03M +$907K +192 New
SI
13
Shaker Investments
Ohio
$846K +$747K +158 New
State Street
14
State Street
Massachusetts
$480K +$421K +89 New
SCA
15
SAC Capital Advisors
Connecticut
$415K +$364K +77 New
Goldman Sachs
16
Goldman Sachs
New York
$403K +$354K +75 New
NFA
17
Nationwide Fund Advisors
Ohio
$372K +$326K +69 New
Geode Capital Management
18
Geode Capital Management
Massachusetts
$307K +$269K +57 New
Morgan Stanley
19
Morgan Stanley
New York
$294K +$260K +55 New
Northern Trust
20
Northern Trust
Illinois
$290K +$255K +54 New
TCIM
21
TIAA CREF Investment Management
New York
$256K +$227K +48 New
SKK
22
Shepherd Kaplan Krochuk
Massachusetts
$245K +$217K +46 New
TA
23
Teachers Advisors
New York
$182K +$161K +34 New
PIM
24
Partner Investment Management
California
$181K +$161K +34 New
BIM
25
Baldwin Investment Management
Pennsylvania
$174K +$151K +32 New
1
2

EIGR Hedge Fund Activity: Q1 2014 in Review

34 of the 3,463 institutional investors tracked by Wall St. Rank reported a position in Eiger BioPharmaceuticals, Inc. (EIGR) for Q1 2014, worth a combined $73.1M.

Buyers outnumbered sellers: 34 funds opened new EIGR positions and 0 closed out — a net gain of 34 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Palo Alto Investors, opening a new position worth an estimated $15.7M.

  • 34 institutional investors held Eiger BioPharmaceuticals, Inc. (EIGR) as of Q1 2014, up from 0 in Q4 2013.
  • Funds reported $73.1M of Eiger BioPharmaceuticals, Inc. stock for Q1 2014.
  • 34 funds opened new Eiger BioPharmaceuticals, Inc. positions in Q1 2014 and 0 closed out, a net change of +34 holders.
  • The largest Eiger BioPharmaceuticals, Inc. buyer in Q1 2014 was Palo Alto Investors, an estimated $15.7M added.

Based on aggregated 13F filings for Q1 2014.